Doxycycline Hyclate Delayed-Release Tablets
In accordance with the Rules and Procedures of the 2010–2015 Council of Experts, the Monographs—Small Molecules 1 Expert Committee has revised the Doxycycline Hyclate Delayed-Release Tablets monograph. The purpose of the revision is to add Dissolution Test 3 for a generic product approved by the FDA.
The Doxycycline Hyclate Delayed-Release Tablets Revision Bulletin supersedes the currently official monograph. The Revision Bulletin will be incorporated in the Second Supplement to USP 35–NF 30.
Should you have any questions, please contact Ahalya Wise, M.S. (301-816-8161 or aww@usp.org).


Follow Us On: